C
Center for Clinical and Cosmetic Research | Aventura, FL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
STP705
ALA
BBI-4000
Aminolevulinic Acid
ACZONE
Remlarsen
Dapsone
HTU-520
Povorcitinib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 26 total trials
Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of AI-09, a Ready-to-Use Liquid Injectable Botulinum Toxin.
Active, not recruiting
Glabellar Lines
Biological: AI-09 Ready Use Injectable Botulinum Toxin
Biological: Vehicle
The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.
Enrolling
Prurigo Nodularis
Drug: Placebo
Drug: Povorcitinib
Trial sponsors
S
T
B
C
D
E
H
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems